Infectious Diseases in Critical Care Medicine

(ff) #1

  1. Fowler RA, Flavin KE, Barr J, et al. Variability in antibiotic prescribing patterns and outcomes in
    patients with clinically suspected ventilator-associated pneumonia. Chest 2003; 123(3):835–844.

  2. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care
    units of Argentina. Infect Control Hosp Epidemiol 2004; 25(3):251–255.

  3. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January
    1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32(8):470–485.

  4. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-
    associated pneumonia: a systematic review. Crit Care Med 2005; 33(10):2184–2193.

  5. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia
    in critically ill patients. Ann Intern Med 1998; 129(6):433–440.

  6. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic
    obstructive pulmonary disease. N Engl J Med 1995; 333(13):817–822.

  7. Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and
    conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998;
    339(7):429–435.

  8. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with
    pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344(7):481–487.

  9. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated
    pneumonia in a large U.S. database. Chest 2002; 122(6):2115–2121.

  10. Ibrahim EH, Ward S, Sherman G, et al. A comparative analysis of patients with early-onset vs late-
    onset nosocomial pneumonia in the ICU setting. Chest 2000; 117(5):1434–1442.

  11. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and
    outcome of ventilator-associated pneumonia. Chest 1993; 104(4):1230–1235.

  12. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-
    associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir
    Crit Care Med 1999; 159(4 Pt 1):1249–1256.

  13. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study
    evaluating attributable mortality and hospital stay. Am J Med 1993; 94(3):281–288.

  14. Parker CM, Kutsogiannis J, Muscedere J, et al. Ventilator-associated pneumonia caused by
    multidrug-resistant organisms orPseudomonas aeruginosa: prevalence, incidence, risk factors, and
    outcomes. J Crit Care 2008; 23(1):18–26.

  15. Kollef KE, Schramm GE, Wills AR, et al. Predictors of 30-day mortality and hospital costs in patients
    with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative
    bacteria. Chest 2008; 134(2):281–287.

  16. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the
    Canadian health care system. J Crit Care 2008; 23(1):5–10.

  17. Niederman MS, Craven DE, Bonten MJ, et al. Guidelines for the management of adults with
    hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit
    Care Med 2005; 171(4):388–416.

  18. Anonymous. Coliform organisms in the pharynx. Lancet 1970; 1(7637):75.

  19. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165(7):867–903.

  20. Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia. A multivariate analysis of risk and
    prognosis. Chest 1988; 93(2):318–324.

  21. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia
    in mechanically ventilated patients. Am Rev Respir Dis 1990; 142(3):523–528.

  22. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an old
    disease. Chest 1995; 108(2 suppl):1S–16S.

  23. Johanson WG Jr, Pierce AK, Sanford JP, et al. Nosocomial respiratory infections with gram-negative
    bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 1972; 77(5):701–706.

  24. Stout J, Yu VL, Vickers RM, et al. Potable water supply as the hospital reservoir for Pittsburgh
    pneumonia agent. Lancet 1982; 1(8270):471–472.

  25. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve
    compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356(9238):1307–1312.

  26. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340(8):627–634.

  27. Craven DE, Steger KA. Nosocomial pneumonia in mechanically ventilated adult patients:
    epidemiology and prevention in 1996. Semin Respir Infect 1996; 11(1):32–53.

  28. Garrouste-Orgeas M, Chevret S, Arlet G, et al. Oropharyngeal or gastric colonization and nosocomial
    pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA
    analysis. Am J Respir Crit Care Med 1997; 156(5):1647–1655.

  29. Scheld WM. Developments in the pathogenesis, diagnosis and treatment of nosocomial pneumonia.
    Surg Gynecol Obstet 1991; 172(suppl):42–53.


Nosocomial Pneumonia in Critical Care 197

Free download pdf